Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

ClinicalTrials.gov ID: NCT02923921

Public ClinicalTrials.gov record NCT02923921. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of pegilodecakin in combination with FOLFOX versus FOLFOX alone in participants with metastatic pancreatic cancer as measured by overall survival.

Study identification

NCT ID
NCT02923921
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
567 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2017
Primary completion
Sep 8, 2019
Completion
Mar 4, 2020
Last update posted
Oct 18, 2020

2017 – 2020

United States locations

U.S. sites
57
U.S. states
28
U.S. cities
52
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234
Cancer Treatment Centers of America Goodyear Arizona 85338
University of Arizona Cancer Center Phoenix Arizona 85004
Comprehensive Blood and Cancer Center Bakersfield California 93309
St. Joseph Heritage Healthcare Fullerton California 92935
USC Norris Cancer Hospital Los Angeles California 90033
TRIO - Translational Research in Oncology-US, Inc. Los Angeles California 90095
UCLA Medical Center Los Angeles California 90095
Cancer Care Associates Medical Group Redondo Beach California 90277
Central Coast Medical Oncology Corporation Santa Maria California 93454
Rocky Mountain Cancer Center Denver Colorado 80218
Georgetown University Medical Center Washington D.C. District of Columbia 20007
Lynn Cancer Institute Ctr for Hem-Onc Boca Raton Florida 33486
Memorial Regional Hospital/Joe Dimaggio Childrens Hospital Hollywood Florida 33021
Baptist Cancer Institute Jacksonville Florida 32207
Watson Clinic Lakeland Florida 33805
Florida Hospital Cancer Institute Orlando Florida 32804
UF Health Cancer Center- Orlando Health Orlando Florida 32806
Northeast Georgia Cancer Care, LLC Athens Georgia 30607
Southeastern Regional Medical Center Newnan Georgia 30265
Saint Alphonsus Regional Medical Center Caldwell Idaho 83605
Decatur Memorial Hospital Decatur Illinois 62526
Fort Wayne Oncology & Hematology Fort Wayne Indiana 46815
St. Elizabeth Medical Center Edgewood Kentucky 41017
Norton Cancer Institute Louisville Kentucky 40202
Hematology Oncology Clinic Baton Rouge Louisiana 70808
New England Cancer Specialists - Scarborough Scarborough Maine 04074
Committee on Clinical Investigations (CCI)- Beth Isreal Deaconess Medical Center IRB Boston Massachusetts 02215
University of Massachusetts Medical Center Worcester Massachusetts 01655
Virginia Piper Cancer Institute Minneapolis Minnesota 55407
St Louis Cancer Care Bridgeton Missouri 63044
Summit Medical Group Summit New Jersey 07902
North Shore Hematology Oncology Associates East Setauket New York 11733
Winthrop University Hospital Mineola New York 11501
Duke University Medical Center Durham North Carolina 27710
Novant Health, Oncology Research Institute Winston-Salem North Carolina 27103
Gabrail Cancer Center Canton Ohio 44718
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73190
Oregon Health and Science University Portland Oregon 97239
Gettysburg Cancer Center Gettysburg Pennsylvania 17325
Eastern Regional Medical Center Philadelphia Pennsylvania 19124
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232-1305
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203
Tennessee Oncology PLLC Nashville Tennessee 37203
Texas Oncology-Austin Midtown Austin Texas 78705
Texas Oncology-Plano East Plano Texas 75075
Texas Oncology - San Antonio Medical Center San Antonio Texas 78240
US Oncology The Woodlands Texas 77380
Hope Cancer Center of East Texas Tyler Texas 75701
Texas Oncology - Tyler Tyler Texas 75702
Texas Oncology-Wichital Falls Texoma Cancer Center Wichita Falls Texas 76310
University of Utah School of Medicine Salt Lake City Utah 84132
Virginia Cancer Institute Richmond Virginia 23230
Medical Oncology Associates, PS Spokane Washington 99208
MultiCare Regional Cancer Center - Auburn Tacoma Washington 98002
Aurora West Allis Medical Center Green Bay Wisconsin 54308
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02923921, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 18, 2020 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02923921 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →